Summit Securities Group’s CONMED CNMD Stock Holding History

Summit Securities Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10	Closed	–	–	627
2014 Q3	$0	Buy	+10	New	+$397	﹤0.01%	716

Other funds holding CNMD

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Coppersmith Capital Management New York $105M AUM 8.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Summit Securities Group's CNMD Position: Q4 2014 in Review

Summit Securities Group sold out of CONMED (CNMD) in Q4 2014, closing a stake of 10 shares.

Summit Securities Group first reported a position in CNMD in Q3 2014 and held it in 1 quarter. The position peaked at $0 in Q3 2014. 156 funds tracked by Wall St. Rank hold CNMD as of Q4 2014.

Summit Securities Group reported no remaining CONMED position as of Q4 2014 after selling out during the quarter.
Summit Securities Group sold 10 CONMED shares in Q4 2014.
Summit Securities Group first reported a position in CONMED in Q3 2014 and held it in 1 quarter.
Summit Securities Group's CONMED position peaked at $0 in Q3 2014.
156 funds tracked by Wall St. Rank held CONMED as of Q4 2014.

Based on Summit Securities Group's 13F filing for Q4 2014, filed 5 Feb 2015.